Injective (INJ) is currently trading at $2.94, reflecting a 3.03% increase over the last 24 hours. The price has hovered at a daily high of $2.94 and a low of $2.85, indicating a tight daily range of only 0.09%, which suggests limited volatility in the short term.

The trading volume for the last 24 hours stands at approximately $43.2 million, translating to a Vol/Market Cap ratio of 14.68%. This volume is significant relative to the market cap, indicating strong trading interest and liquidity, which could support price stability or further upward movement.

Analyzing the hourly moving averages, the 8 SMA is at $2.91 with a 0.88% gain, while the 13 and 21 SMAs show positive momentum of 1.47% and 1.72%, respectively. Notably, the 144 SMA reflects a 2.01% increase, suggesting that the trend is moderately bullish in the short term.

The 1-hour RSI is currently at 74, indicating that INJ is overbought in the very short term, which could lead to a price correction. In contrast, the 7-day RSI at 50 suggests neutral momentum, with no immediate signs of bearish pressure despite recent price declines over the past week (-5.13%) and two weeks (-8.26%).

Given the all-time high of $52.62 reached in March 2024, current price levels represent a significant opportunity for potential recovery. However, the recent negative price changes and the overbought status indicated by the 1-hour RSI necessitate caution in immediate trading decisions.

In conclusion, the analysis suggests a cautious approach at the current price level. The combination of overbought conditions and recent price declines leads to a Hold rating, indicating that investors should monitor the situation closely for signs of a potential correction or rebound before making further investment decisions.